Skip to main content
Kidney360 logoLink to Kidney360
. 2022 Nov 28;4(1):41–53. doi: 10.34067/KID.0005582022

Context Matters: A Qualitative Synthesis of Adherence Literature for People on Hemodialysis

Kathryn S Taylor 1,, Ebele M Umeukeje 2, Sydney R Santos 3, Katherine C McNabb 1, Deidra C Crews 4, Melissa D Hladek 1
PMCID: PMC10101575  PMID: 36700903

graphic file with name kidney360-4-041-g001.jpg

Keywords: dialysis, end-stage kidney disease, food security, health equity, hemodialysis, patient-centered outcomes, qualitative research, treatment adherence

Abstract

Key Points

  • Qualitative research that explores hemodialysis patient perspectives about adherence may point to gaps in existing adherence interventions.

  • Patients' goals included balancing treatment and competing priorities, preserving a sense of their “old selves,” and minimizing symptoms.

  • Adherence may improve when clinicians routinely elicit patients' goals and partner to resolve conflicts between those goals and adherence.

Background

Patients with ESKD treated with hemodialysis in the United States have persistently higher rates of nonadherence compared with patients in other developed countries. Nonadherence is associated with an increased risk of death and higher medical expenditure. There is an urgent need to address it with feasible, effective interventions as the prevalence of patients on hemodialysis in the United States continues to grow. However, published adherence interventions demonstrate limited long-term efficacy.

Methods

We conducted a synthesis of qualitative studies on adherence to hemodialysis treatment, medications, and fluid and dietary restrictions to identify gaps in published adherence interventions, searching PubMed, CINAHL, PsychInfo, Embase, and Web of Science databases. We analyzed qualitative data with a priori codes derived from the World Health Organization's adherence framework and subsequent codes from thematic analysis.

Results

We screened 1775 articles and extracted qualitative data from 12. The qualitative data revealed 20 factors unique to hemodialysis across the World Health Organization's five dimensions of adherence. In addition, two overarching themes emerged from the data: (1) adherence in the context of patients' whole lives and (2) dialysis treatment as a double-edged sword. Patient-level factors reflected in the qualitative data extended beyond knowledge about hemodialysis treatment or motivation to adhere to treatment. Patients described a profound grieving process over the loss of their “old self” that impacted adherence. They also navigated complex challenges that could be exacerbated by social determinants of health as they balanced treatment, life tasks, and social roles.

Conclusions

This review adds to the growing evidence that one-size-fits-all approaches to improving adherence among patients on hemodialysis are inadequate. Adherence may improve when routine care incorporates patient context and provides ongoing support to patients and families as they navigate the logistical, physical, and psychological hardships of living with dialysis. New research is urgently needed to guide a change in course.

Introduction

The number of people living with ESKD in the United States may surpass one million by the year 2030.1 Hemodialysis remains the primary KRT.2 Patients with ESKD receiving hemodialysis in the United States have a 33% increased risk of death compared with similar patients in Europe and a nearly four-fold increase compared with patients in Japan.3 Relatively higher rates of nonadherence to hemodialysis treatment, medications, or fluid and dietary restrictions may explain some of this disparity.4,5 In a recent analysis from the Dialysis Outcomes and Practice Pattern Study, nearly 25% of hemodialysis patients in the United States missed at least one dialysis treatment in a 4-month period compared with <1% of patients in Japan.6 US hemodialysis patients also report skipping their phosphate binders more frequently than patients in other developed countries.7 In addition to mortality, nonadherence is associated with increased hospitalization and medical expenditure.8 Given the increasing prevalence of hemodialysis patients in the United States and the persistence and costliness of nonadherence, there is an urgent need to address it with feasible, effective interventions.

Published interventions addressing adherence among patients on hemodialysis, however, demonstrate limited long-term efficacy.911 A recent systematic review and meta-analysis by Murali and colleagues10 included 33 randomized controlled trials (RCTs) evaluating hemodialysis treatment, medication, or fluid and dietary restriction adherence interventions. Many adherence interventions were informed by health behavior change models such as social cognitive theory or the Health Belief Model, although partially applied. Despite recognition of the burden of social determinants of health in the hemodialysis population,12 nearly all adherence interventions focused on the patient level (i.e., fixed and modifiable characteristics of individual patients). Of the 12 that demonstrated efficacy, only 2 sustained positive effects at 12 months. The mechanisms underlying the positive effects were not clear and did not directly align with the theory guiding intervention development.13,14 In addition, in meta-analysis, there was no association between intervention efficacy and the role or expertise of individuals delivering the interventions, the underlying theory, or the type of intervention (e.g., educational or psychological).10

Given that current adherence research has not clarified necessary components for sustained improvement, further exploration of the qualitative data are needed. Qualitative research about adherence that explores the perspectives of patients on hemodialysis in the United States may point to gaps in existing interventions. Analogous to meta-analysis, qualitative synthesis is a method to integrate qualitative data from different studies that address the same research question. The product of a qualitative synthesis may be a new conceptual model or theory that explains an outcome of interest. Researchers have conducted qualitative syntheses to develop conceptual models for medication adherence among patients with CKD. However, one synthesis excluded patients on KRT,15 and one included patients across all CKD stages and on hemodialysis or peritoneal dialysis.16 Hemodialysis patient perspectives on adherence across all domains of the ESKD treatment regimen remain largely unknown. Therefore, the aim of this review was two-fold: (1) to synthesize qualitative data from patients on hemodialysis in the United States about adherence to hemodialysis treatment, medications, or fluid and dietary restrictions, and (2) to apply findings to existing theoretical frameworks to inform the development of effective, patient-centered interventions.

Methods

Below, we report our qualitative synthesis per the 21-item ENhancing Transparency in REporting the synthesis of Qualitative research (ENTREQ) checklist.17

We conducted a “best fit” framework synthesis of qualitative data as described by Carroll and colleagues.18 The “best fit” framework synthesis consists of clarifying a research question that can be answered by qualitative research, conducting a systematic review of qualitative literature, and completing a thematic analysis of qualitative data extracted from included studies. The thematic analysis consists of deductive and inductive processes. The result is a new, tailored conceptual framework supported by qualitative data and a transparent, more replicable synthesis.

We conducted a literature search for publications in the English language to answer the research question: How do adult hemodialysis patients experience adherence to hemodialysis treatment? We intentionally framed the research question broadly to capture a wide range of adherence factors from the literature. Relevant search terms and medical subject headings were identified with support from an informationist (Supplemental Material). We searched PubMed, CINAHL, PsychInfo, Embase, and Web of Science databases. We did not restrict the search by publication date. Two authors (S.R.S. and K.S.T.) independently completed title and abstract screening and resolved discrepancies through discussion. One author (K.S.T.) screened full-text articles.

We adopted an inclusive approach during the title and abstract screening to reduce the likelihood of missing relevant literature. After removing duplicates, peer-reviewed studies were included for full-text review if researchers applied qualitative methods and the study sample included adult hemodialysis patients. We included qualitative or mixed methods studies for full-text review that explored patient experiences on dialysis even if they did not explicitly address adherence in the title or abstract. Despite calls for standard measures of hemodialysis treatment adherence, none of them currently exist.19 Conceptually, adherence could apply to any recommended treatment, and articles reporting patient perspectives on less common indicators of adherence (e.g., vascular access cleaning at home) were included in the full-text review.

Studies were excluded on full-text review if the qualitative data did not address adherence among patients on hemodialysis. If studies included other chronic diseases or dialysis modalities, we excluded them when we could not ascertain whether hemodialysis patients were the source of qualitative data. We also excluded studies if the sample was not United States-based. Although some factors related to hemodialysis treatment adherence may be universal (e.g., fatigue) others are unique to setting (e.g., accessibility of hemodialysis services). We anticipated that by including only United States-based studies, we would achieve saturation on “universal” experiences while identifying factors in the social, economic, and treatment domains that were unique to the United States. Finally, we excluded one study that reported results (i.e., codes derived from qualitative data) but did not report qualitative data (i.e., representative quotes).20

Finally, we conducted a quality appraisal per criteria from Carroll and colleagues.21 Quality appraisal methods for qualitative research are subject to debate.22 Researchers disagree on quality criteria and note that any appraisal is limited by the comprehensiveness of study reporting. In addition, quality appraisal checklists for qualitative studies have demonstrated limited interrater reliability perhaps because of the subjective nature of certain criteria.23 Given these issues, Carroll and colleagues have demonstrated that an assessment of “the auditability and transparency of the methods of each study” is an empirical, pragmatic, and likely sufficient form of an appraisal. Adequately reported studies described at least two of the following four elements: study question and design, sampling approach, data collection methods, and data analysis methods (Table 1).21 We concluded that a simpler quality appraisal approach would reduce the likelihood of excluding studies that were not clearly reported but might contain rich and relevant qualitative data.

Table 1.

Details from included studies

Study Research Aim and Design Sample Data Collection and Interview/Focus Group Questions (Select) Reported Data Analysis Method Quality Appraisal of Methods Reporting
Boehmer et al., 202130 To examine patient and healthcare practices associated with higher and lower levels of illness and treatment burden
Explanatory mixed methods study; qualitative arm applied qualitative descriptive design
Purposive sample of 23 patients on ICHD and home modalities scoring high or low on illness and treatment burden scales
English-speaking, no cognitive impairment
Semistructured interviews
“What does your typical full day look like on your dialysis days?”
“What do you find are the biggest problems of being on dialysis?”
Grounded theory ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Chenitz et al., 201428 To explore patient attitudes about dialysis, health beliefs related to missed treatments, barriers, and facilitators to attendance
Qualitative descriptive study
Purposive sample of 15 nonadherent and 15 adherent patients on ICHD
On ICHD ≥6 months, ≥18 y/o, English-speaking
Semistructured interviews
“Can you tell me about what helps you make it to your treatments?”
“If you were able to redesign the system, what would you like to see changed to make it easier for you to get dialysis”
Grounded theory ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Clark-Cutaia et al., 201933 To explore barriers to following the hemodialysis diet
Qualitative descriptive study
Purposive sample of 30 patients on ICHD enrolled in RCT, selected for “racial and economic and diversity”
ICHD ≥3 mo, ≥18 y/o
Telephone interviews
“What are the things that get in the way of eating a healthy diet?”
“How does money influence whether or not you are able to follow the hemodialysis diet?”
Thematic analysis ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Karolich and Ford, 201035 To explore how older adults with ESKD attach meaning to their illness, and how that meaning is related to illness comprehension and management
Concurrent mixed methods study; qualitative arm applied qualitative descriptive design
Purposive sample of 10 adults on ICHD scoring high or low on orientation to Life scale
ICHD ≥6 mo, ≥50 y/o
Semistructured interviews
“What is the main reason you come to dialysis and follow the treatment plan prescribed by your doctor?”
Interview responses are grouped according to concepts in the Orientation to Life Scale ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Krueger, 200937 To explore Hmong experiences with hemodialysis and experiences of nurses working with Hmong patients
Qualitative descriptive study
Three male Hmong patients on ICHD Interviews during dialysis treatment
Questions not reported
Thematic analysis ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
O'Brien, 199027 To examine relationships between social support and compliance behavior among maintenance hemodialysis patients
Explanatory mixed methods study; qualitative arm applied qualitative descriptive design
Thirty-three patients on ICHD enrolled in 9-yr longitudinal cohort study
ICHD approximately 12–18 mo, ≥18 y/o; excluded patients with diabetes, cancer, heart disease, pulmonary disease, and psychiatric conditions
Interviews guided by the “Dialysis Patient Focused Interview Guide” Not reported ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
Χ Data analysis methods
Parker et al., 201731 To explore self-management strategies and experiences of medication management among patients on hemodialysis
Qualitative descriptive study
13 patients on ICHD
≥18 y/o, English-speaking; excluded patients living in long-term care or assisted living facilities
Semistructured interviews with 1–2 patients at a time Thematic and framework analysis ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Robinson et al., 201929 To explore Black older adults' experiences living with ESKD and on dialysis
Qualitative descriptive study
Purposive sample of 16 Black patients on ICHD
≥65 y/o, oriented to person, place, time
Interviews during dialysis treatment or at participants' homes
“Tell me about your experience with end-stage renal disease”
Thematic analysis ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Smith et al., 201036 To describe patient experiences with fluid management to guide adherence interventions
Qualitative descriptive study
Convenience sample of 19 patients on ICHD
≥18 y/o, English-speaking, able to give informed consent
Focus groups
“What makes you feel more confident in your ability to meet your fluid goals?”
Content analysis ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Senteio and Veinot, 201434 To describe the “work” of adherence among African Americans who live in high-poverty communities and how “visible” it is to healthcare providers
Qualitative descriptive study
Purposive sample of 37 patients with at least two of the following: hypertension, diabetes, CKD (including on ICHD)
Participants represent sex, age, racial composition of urban population in a US state
Semistructured interviews in private locations
Questions not reported
Straussian grounded theory systematic approach ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Tijerina, 200938 To explore psychosocial, cognitive, and cultural factors that shape adherence behavior in Mexican American women
Qualitative descriptive study
Purposive sample of 26 Mexican American women on ICHD
ICHD ≥6 months, 30–55 y/o
Interviews in patients' homes
Questions not reported
Thematic analysis from social constructivist perspective ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods
Wells, 201532 To explore occupational changes and perceptions experienced by Mexican Americans with ESKD and their families living with dialysis
Phenomenological design
17 Mexican American patients with ESKD and their family members
Patients on ICHD ≥6 mo
Semistructured interviews at dialysis centers or patients' homes
Questions not reported
Thematic analysis ✓ Study question and design
✓ Sampling approach
✓ Data collection methods
✓ Data analysis methods

ICHD, in-center hemodialysis; RCT, randomized controlled trial.

The following data were extracted from included studies: Author name, date of publication, research question, study design, sampling strategy, data collection and analysis methods, interview or focus group questions, and participant quotes. We also extracted conclusions that the authors drew directly from participant quotes. We did not extract primary study results (i.e., concepts and conceptual models) because the unit of analysis in the “best fit” framework synthesis method is primary qualitative data (i.e., participant quotes).24

Thematic Analysis

Two authors (M.D.H. and K.S.T.) conducted a thematic analysis25 to synthesize qualitative data from included studies, using f4analyze software, version 3.1.1. The initial codebook consisted of the World Health Organization's (WHO) five adherence dimensions. In its 2003 report, the WHO described adherence as a “multidimensional phenomenon,” determined by social and economic, health care system, condition-related, therapy-related, and patient-related dimensions.26 For example, factors in the social and economic dimension include poverty, food insecurity, and social support. Broader theories, such as social cognitive theory, can explain adherence behavior with concepts from the WHO adherence framework. In addition, Murali and colleagues10 used the WHO adherence framework to categorize RCTs in their systematic review and meta-analysis of hemodialysis treatment adherence interventions.

One author (K.S.T.) completed initial coding (deductive process). Both authors independently reviewed the qualitative data and created a list of new codes and potential themes emerging from it (inductive process). The codebook and its structure were refined iteratively via discussion of the codes' conceptual definitions, explanatory power, and overarching themes. One author (K.S.T.) then recoded the data using the refined codebook. A third author (S.R.S.) separately coded qualitative data from 20% of the articles to assess the coherence of each code and the thoroughness of coding overall. Disagreements were resolved via discussion.

Results

Our search queries yielded 1775 unique articles. Twelve studies were included in the “best fit” framework synthesis (Figure 1). Table 1 provides a summary of included articles and the results of our quality appraisal. All studies were adequately reported with one study27 meeting three out of four criteria and 11 studies meeting four out of four criteria.

Figure 1.

Figure 1

Flow diagram of literature search and selection.

Figure 2 displays a new adherence framework for patients on hemodialysis derived from the WHO adherence framework and our inductive qualitative data analysis. Table 2 includes examples of representative qualitative data. The qualitative data revealed 20 factors (i.e., subcodes) unique to hemodialysis across the five WHO adherence dimensions. In addition, two overarching themes emerged from the data: (1) adherence in the context of patients' whole lives and (2) dialysis treatment as a double-edged sword).

Figure 2.

Figure 2

Adapted WHO adherence framework for people on hemodialysis.

Table 2.

Factors impacting adherence for people on hemodialysis with supporting qualitative data

Social and economic factors
 Financial strain “Sometimes I skip my medicine. It's just another day or a couple days and then I'll just go ahead instead of going to get my medicine if I am going somewhere with somebody, I will keep those $2.00 to get something I can stretch for a long time. Like the ground beef I can make something I can eat two or three times.” [Clark-Cutaia et al., 201933]
“Right now I think the cost [of medications] is astronomical for us. ’Cause I take multiple pills. The pharmacist will say, ‘Do you realize how much this is?,’ and I said, ‘It doesn't matter.’ I put it on the credit card and you gotta have it. You gotta have it. The phosphorus binders are ridiculous.” [Parker et al., 201731]
 Food insecurity “Well I ain't gone (sic) starve myself to death. I'll do what I can to follow that diet, but if I can't afford it, then I eat what I can. It is just that simple.” [Robinson et al., 201929]
 Support from friends or family And if I look at it and the day is going by and I didn't take no pills, I go, ‘Uh oh, I forget to take my pill.’ ‘Cause sometimes she's not around, my wife, and when she comes back and they're in there. Oh boy, does she jump on me. She jumps all over me.” [Parker et al., 201731]
 Support from peers “You know you gone (sic) feel kinda down… But you know since I been coming here everybody that waits on you is so nice and then you get used to the people you come in with. That helps a whole lot.” [Robinson et al., 201929]
Health system related
 Support from clinicians “They make it feel like I'm at home almost. They provide that level of comfortability. And when—and just like at home, you know, you start messing up, and they always jumping on your case.” [Chenitz et al., 201428]
 Patient and family education or comprehension “They speak in a Latin tongue and I don't understand. I have to say, ‘Wait a minute. What do you mean by that?’ And they just jibber, jibber, jibber.” [Robinson et al., 201929]
“My attendance is better, way better than it was . . . Because I was told in—well, they told me, you know, that I need it, and they gave me some reasons why, you know. They said, now, you know how you was feeling before you started getting it. Just imagine if you stop getting it, you know, and it made sense.” [Chenitz et al., 201428]
 Transportation to/from dialysis “Sometimes I have to sit and wait at least an hour and I have to call and say my ride is not here yet, which makes me late getting there, which makes me late getting on the machine, which makes me late getting off the machine. And then . . . coming to pick you up, if you're not ready when they get there, they will leave you and you'll have to sit and wait and wait and wait” [Chenitz et al., 201428]
Condition-related factors
 Disability or loss of function “I can't even make up my bed. Ah, I can't sweep my floor, now I can't even ah, fix my lunch, put it on a plate and put it in the refrigerator…Some days I'm too weak to even put it in the microwave and warm it and to eat it. I feel wore out.” [Robinson et al., 201929]
 Feeling/not feeling sick “What really helps me [adhere to a fluid restriction] is remembering what it’s like to not breathe.” [Smith et al., 201036]
“I understand, they are saying that certain foods are not good for you. You know for your kidneys, but I haven't been observing that too much. I like going by trial and error. I like to go with how I feel.” [Clark-Cutaia et al., 201933]
“At first I followed the diet rigorously but I just found myself getting weaker and weaker. I found that by eating more I felt better. I don't go way off the diet though, only within the bounds of what I know I can do.” [O'Brien, 199027]
Therapy-related factors
 Life sustaining nature of dialysis “I don't like it, but you know, it keeps me alive, so I got to do it.” [Chenitz et al., 201428]
“The machine and that tech in there are my crutch. I know I can come in and they are going to take care of it [excess fluid].” [Smith et al., 201036]
 Treatment makes you feel worse/questioning treatment “The thing that bothers me is the medicine they give me to help me, but then I take them and they should make me feel better and have a better appetite, but I don't feel better, and I'm just sort of worried about that. And if the medicine that will help me doesn't help me, I don't want to take it anymore.” [Krueger, 200937]
 Length of dialysis “If you don't eat before you get up and get out, and then you're hungry when you get out, and there really isn't a place where you can get some regular food. You might go to McDonald's and all that fast food really isn't good for you.” [Clark-Cutaia et al., 201933]
 Craving food or fluid “It's like when you're on a diet and you are not supposed to eat. When you are not supposed to drink, that's all you think about.” [Smith et al., 201036]
 Complexity of treatment “I get stuck on one thing like trying to watch my protein or my phosphorous and I'll forget about the other stuff.” [Smith et al., 201036]
Patient-related factors
 Hating, fearing, or dreading dialysis “Dialysis is like a crummy job, the people here aren't nice, and the other people on dialysis are depressing. I have to drag myself here. I hate it.” [Karolich and Ford, 201035]
 Depression or anxiety about the future “I'm always thinking what kind of life I'm gonna have. Am I going to be okay? Is dialysis really going to work for me? Before, I had a very good attitude about life, but now . . . I worry constantly.” [Tijerina, 200938]
 Grief over/acceptance of loss of old self “All my friends. All of ’em. As soon as I got sick and had to quit drinking and wasn't hanging out in the bars and wasn't doing physical things anymore, all of ’em, they went their direction and I went my direction. I don't see anybody anymore at all, which is too bad. That's the way it worked out, but what do you do when you're no fun anymore? You don't do anything fun. You're not fun. We're going to where we can have fun. Okay. I can't blame ’em. I might be the same way if I was in their situation.” [Boehmer et al., 202129,30]
“It was terrible, I almost went crazy, because I couldn't accept it….but after praying and meditating with the Lord, I learned to accept it….To tell you the truth I was supposed to be a Christian, and my husband was not saved. He kinda pushed me through it, because he said, ‘Now look, if I can understand it, ah, what the Lord is doing to you, why you can't understand it?” [Robinson et al., 201929]
 Balancing treatment and life “I would imagine, too, for some people, not me personally, but balancing work and dialysis would be hard because some employers just don't understand how important it is. I've heard horror stories of bosses who really don't know that it’s a life and death situation, and they make people work, but for me personally, my employers always worked very well with whatever I had.” [Boehmer et al., 202127,30]
“Once in a while you have got to go out and have a beer and pizza with your friends. You can do it if you watch what you eat the day before, and then, too, you only have one piece of pizza and one glass of beer.” [O'Brien, 199027]
 Desire for tailored treatment “Everybody is different. Our needs are different. You have to respond to the people who have the means and the ones that [don't] have the means. You know what I mean?” [Clark-Cutaia et al., 201933]
 Self-management strategies “Well what I do is the pills that have two a day, I write on the top of it ‘2’ with a marker. And the ones that have one, I put ‘1’ on it. They're mostly all to do with one day, two a day or one a day. So that's how I line them up and in the morning I take the ones that are two a day, I take one of each, and then at noon-time I take the rest of the other ones for one a day.” [Parker et al., 201731]

Adherence in the Context of Patients' Whole Lives

Patient education or comprehension was a recurring code in nearly all studies. In some cases, patients described how education improved adherence, particularly when it helped them anticipate how dialysis, medications, or fluid and dietary nonadherence would make them feel.28 Some patients found educational information confusing.29 However, multiple authors noted that patient comprehension (or lack thereof) did not ultimately determine adherence behavior. Instead, patients explained adherence behavior in the context of their whole lives.

Patients described the perpetual challenge of balancing all aspects of ESKD treatment with family or social roles and logistics. For example, patients balanced their hemodialysis treatment and work schedules30, paying for medication refills and other nonmedical expenses31, and fluid or dietary restrictions and the desire to socialize with friends on holidays.27 For some patients, life balance was further complicated by financial strain, which could be caused or exacerbated by employment changes caused by hemodialysis.32 Patients described tradeoffs between food and medications to stretch inadequate finances and challenges with dietary adherence because of the cost of food (e.g., the relative cost of salt compared with more expensive salt substitutes).33 Financial strain also contributed to psychological stress.34 Financial strain and food insecurity were reported in studies that sampled exclusively or predominantly Black or Hispanic patients.29,3234

“Transportation” and “loss of function” were additional contextual factors that could impact hemodialysis treatment attendance or adherence to medications and dietary restrictions. For example, some patients described feeling too weak at home to prepare healthy meals or eat.29 Although these subcodes appeared infrequently, we included them as distinct subcodes because of their relevance in existing adherence literature.

Some patients perceived the disconnect between standard education and their individual circumstances and felt that education should be more tailored. For example, patients believed that dietary recommendations should account for their limited finances or their perceived good health.33,35 Contextual barriers to adherence were not always visible to dialysis clinicians and staff.34 Instead, patients reported seeking and receiving help from family and friends. Social support existed on a spectrum with some patients managing medications, transportation, or dietary restrictions in partnership with family members and others relying on them completely.3032 Patients also self-managed ESKD treatment, at times in creative ways. For example, patients struggling with food insecurity described purchasing groceries for the ESKD diet at “lower quality,” cheaper grocery stores.33 Others had unique strategies to organize their medications.31

Treatment as a Double-Edged Sword

Patients across multiple studies acknowledged that adherence to dialysis treatment, medications, and fluid or dietary restrictions could prolong their lives and alleviate negative symptoms.2830,36 However, patients also described adherence as making them feel worse physically, and some questioned the benefits or rationale for treatment.37 Dialysis left some feeling tired, hungry, or “depleted.”29 Patients explained that strict dietary adherence made them too weak to function.27 Many described intense food and fluid cravings that were so strong one patient “prayed to the Lord to take that taste [of fresh fruit]” from her.29 Faced with treatment that could make them feel better or worse, patients trusted a subjective sense of “feeling sick” to guide adherence behavior.36

In addition, patients and family members grieved the life they had before dialysis initiation. Patients described their grief more frequently and richly than physical symptoms. Grief impacted nonadherence when patients missed treatment or tested food or dietary restrictions to preserve a sense of their self before dialysis.27 Related but distinct from this grief process were patients' affective responses to dialysis. Patients described feeling afraid watching their blood leave their bodies32 and hated or “dreaded” dialysis like a “crummy job.”35 Although dialysis was life-saving, some patients felt depressed or anxious about the future. One patient stopped making plans because she did not know when she would die.38 For some, a sense of camaraderie or belonging with other patients and dialysis facility staff could improve adherence. Patients described appreciating when clinicians “jumped on their case” when they “started messing up” like they were family.28 Other patients navigated dialysis as a double-edged sword by adhering just enough to preserve a sense of self and stay alive.28

Integrating Themes and Codes with Behavior Theory to Explain Nonadherence

The WHO adherence framework that informed our framework synthesis does not detail causal pathways, and all but one qualitative study in this review used a qualitative descriptive design. Therefore, our adherence framework is descriptive and does not specify how adherence factors interact. However, the same grand theories of human behavior that inform existing adherence interventions can provide guidance.

Figure 3 depicts how adherence factors from our framework can be integrated into social cognitive theory to explain adherence behavior. It also highlights mediating factors that have not been addressed in published adherence RCTs. Researchers have applied social cognitive theory to design patient-level adherence interventions addressing knowledge, self-efficacy, or goal setting. However, social cognitive theory positions knowledge as a precursor for health behavior and stresses the relevance of social and economic factors and outcome expectations, which are not routinely addressed in adherence-related RCTs.

Figure 3.

Figure 3

Integration of social cognitive theory and select adherence factors emerging from the qualitative data. Adapted from Bandura.47 *Mediating adherence factors and relationships unaddressed in published RCTs.

In social cognitive theory, our theme “adherence in the context of patients' whole lives” equates to socio-structural impediments (e.g., financial strain and food insecurity) and facilitators of adherence (e.g., support from friends and family). Our theme, “dialysis as a double-edged sword” speaks to patients' outcome expectations and illuminates that patients on hemodialysis do not always perceive the outcomes of adherence as positive. Finally, social cognitive theory clarifies that patients adhere to treatment if adherence aligns with their goals. Both themes emerging from the qualitative data clarify that hemodialysis patients' goals include balancing treatment and competing priorities, preserving a sense of their “old selves,” and minimizing symptoms. At times, these goals and adherence conflict.

Finally, adherence intervention studies and some of the qualitative studies in this review address individual components of adherence, like fluid management or treatment attendance. However, the integration of themes and codes from our adherence framework with social cognitive theory demonstrates that (1) the complexity of the ESKD regimen contributes to nonadherence and (2) adherence to the regimen as a whole occurs within the context of a combination of adherence factors unique to the individual patient.

Discussion

The adherence framework for people on hemodialysis constructed via our qualitative synthesis included 20 distinct factors within five adherence domains. These factors emerged from qualitative studies sampling patients receiving hemodialysis in the United States, a country with relatively high rates of medication and treatment nonadherence. Patient-level factors reflected in the qualitative data went beyond knowledge about hemodialysis treatment or motivation to adhere to treatment. The qualitative data helped to clarify how more general experiences of life on hemodialysis, such as grief and loss, impacted adherence behavior. In addition, the qualitative data in this review confirmed the relevance of contextual factors beyond the patient level.

Our findings aligned with existing observational adherence research and added richness and context to observational study findings. For example, a comparison of cost-related medication nonadherence across 12 countries found that 29% of dialysis patients in the United States did not purchase medications because of the cost, and this proportion “significantly exceeded that in any other country.”39 A large cohort study of nearly 200,000 patients from one large dialysis organization demonstrated that odds of missing a treatment increased by 20% when patients had depression or relied on van transportation. In addition, patients were nearly twice as likely to miss dialysis treatments when scheduled on holidays or patients' birthdays.40 The qualitative data detailing patients' decisions to miss treatment when they felt well enough or because of competing priorities may explain this finding.

Although some of the adherence factors in our framework have been previously described, many have not been addressed in previous intervention studies. In the systematic review and meta-analysis by Murali and colleagues, nearly all studies intervened at the patient level. For example, interventions included health contracts, cognitive behavioral therapy, and educational videos.10 However, one-size-fits-all approaches to improving individual elements of ESKD adherence among patients on hemodialysis are likely inadequate.41 Instead, interventions can address multiple, concurrent barriers across adherence domains.

Within the social and economic adherence domain, food provision may improve adherence for patients experiencing food insecurity. A food program that provided 100% of daily energy requirements to people living with HIV or diabetes and experiencing food insecurity reduced depressive symptoms and participant tradeoffs between medical care and food. Antiretroviral adherence significantly improved.42 Within the health system domain, our review suggests that adherence may improve when clinicians routinely elicit patients' goals and partner to resolve conflicts between those goals and adherence. Clinicians can develop a therapeutic alliance so patients feel comfortable sharing their experiences and believe that sharing will make a difference in care.43 Rather than targeting individual components of the ESKD regimen, interventions that address treatment and condition adherence domains can provide ongoing support to patients and families as they navigate the logistical, physical, and psychological hardships of living with ESKD and hemodialysis.

Despite a wealth of observational and intervention research on nonadherence among patients on hemodialysis, new research is needed to guide a change in course. Murali and colleagues10 provide excellent recommendations for future intervention trials, such as developing interventions that could be feasibly implemented in practice and controlling for confounding variables when researchers use surrogate markers of adherence. Adherence interventions that concurrently address barriers within multiple adherence domains can include qualitative arms to explain how interventions work when they do. Future intervention research should also apply conceptual models that incorporate race and explicitly address racial equity. Financial strain and food insecurity were important socioeconomic factors impacting adherence that emerged from qualitative studies sampling predominantly or exclusively non-White patients. Multiple studies have demonstrated associations between adherence and patient race, such that White patients have higher rates of adherence across different adherence measures.40,44 A recent perspective piece by Mokiao and Hingorani45 argued that residential segregation and other forms of structural racism impact food security and subsequent racial disparities in CKD incidence and progression. The qualitative data in this synthesis suggest that social determinants of health, such as financial strain and food insecurity, may partially explain racial disparities in hemodialysis treatment adherence as well.

Our framework synthesis has some limitations. Although our search strategy was robust, we may have missed relevant literature. Researchers have described challenges in identifying qualitative studies via systematic review because of limitations in article indexing for qualitative methods.46 In addition, our parsimonious quality appraisal criteria may have resulted in the inclusion of “lower quality” studies that could bias our findings in theory. However, via iterative thematic analysis, we discarded codes that lacked explanatory value.

Researchers have applied diverse methods to deepen our understanding of nonadherence among patients on hemodialysis. Yet, high rates of nonadherence in United States have persisted for decades, signaling that more work is needed. Interventions involving unidirectional information sharing from clinician or expert to patient have demonstrated limited efficacy. The findings of this qualitative synthesis support a growing call that intervention research must incorporate contextual factors, including social determinants of health, into interventional design.

Supplementary Material

SUPPLEMENTARY MATERIAL
kidney360-4-041-s001.pdf (85.3KB, pdf)
kidney360-4-041-s002.pptx (222.2KB, pptx)

Disclosures

K.S. Taylor was the Corporate Vice President of Quality for Fresenius Kidney Care (FKC) from September 2016 through December 2017. K.S. Taylor does not currently have any financial interests, relationship, or commitment with Fresenius Kidney Care. D.C. Crews reports the following: Consultancy: Yale New Haven Health Services Corporation Center for Outcomes Research and Evaluation (CORE); Research Funding: Baxter International; Somatus, Inc.; Honoraria: Maze Therapeutics; Advisory or Leadership Role: Editorial Board—Clinical Journal of the American Society of Nephrology, Journal of Renal Nutrition, Journal of the American Society of Nephrology; Associate Editor, Kidney360; Co-Chair, Bayer HealthCare Pharmaceuticals, Inc. Patient and Physician Advisory Board Steering Committee for Disparities in Chronic Kidney Disease Project; Advisory Group, Health Equity Collaborative, Partner Research for Equitable System Transformation after COVID-19 (PRESTAC), Optum Labs; and Other Interests or Relationships: Board of Directors, National Kidney Foundation of Maryland/Delaware; Nephrology Board, American Board of Internal Medicine; Council of Subspecialist Societies, American College of Physicians. All remaining authors have nothing to disclose.

Funding

K.S. Taylor was supported by National Institute of Nursing Research grant F31NR109461. E.M. Umeukeje was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant 1K23DK114566-01A1 and National Institutes of Health grant 1 R03 DK129626-01. K.C. McNabb was supported by National Institute of Allergy and Infectious Diseases grant F30AI165167. D.C. Crews was supported by National Heart, Lung, and Blood Institute grant K24HL148181. M.D. Hladek was supported by the Johns Hopkins University Older Americans Independence Center of the National Institute on Aging (award P30AG021334).

Author Contributions

K.S. Taylor conceptualized the study and wrote the original manuscript draft; M.D. Hladek and K.S. Taylor developed study design; M.D. Hladek, S.R. Santos, and K.S. Taylor conducted data collection and analysis; and all authors contributed to the review and editing.

Supplemental Material

This article contains the following supplemental material online at http://links.lww.com/KN9/A235.

Relevant search terms and medical subject headings.

References

  • 1.McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrol. 2019;30(1):127–135. doi: 10.1681/asn.2018050531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.United States Renal Data System. USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020 [Google Scholar]
  • 3.Goodkin DA Bragg-Gresham JL Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270–3277. doi: 10.1097/01.asn.0000100127.54107.57 [DOI] [PubMed] [Google Scholar]
  • 4.Saran R Bragg-Gresham JL Rayner HC, et al. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003;64(1):254–262. doi: 10.1046/j.1523-1755.2003.00064.x [DOI] [PubMed] [Google Scholar]
  • 5.Foley RN, Hakim RM. Why is the mortality of dialysis patients in the United States much higher than the rest of the world? J Am Soc Nephrol. 2009;20(7):1432–1435. doi: 10.1681/asn.2009030282 [DOI] [PubMed] [Google Scholar]
  • 6.Al Salmi I Larkina M Wang M, et al. Missed hemodialysis treatments: international variation, predictors, and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2018;72(5):634–643. doi: 10.1053/j.ajkd.2018.04.019 [DOI] [PubMed] [Google Scholar]
  • 7.Fissell RB Karaboyas A Bieber BA, et al. Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: findings from the DOPPS. Hemodial Int. 2016;20(1):38–49. doi: 10.1111/hdi.12315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Plantinga LC King LM Masud T, et al. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018;33(7):1215–1223. doi: 10.1093/ndt/gfx335 [DOI] [PubMed] [Google Scholar]
  • 9.Matteson ML, Russell C. Interventions to improve hemodialysis adherence: a systematic review of randomized-controlled trials. Hemodial Int. 2010;14(4):370–382. doi: 10.1111/j.1542-4758.2010.00462.x [DOI] [PubMed] [Google Scholar]
  • 10.Murali KM, Mullan J, Roodenrys S, Hassan HC, Lambert K, Lonergan M. Strategies to improve dietary, fluid, dialysis or medication adherence in patients with end stage kidney disease on dialysis: a systematic review and meta-analysis of randomized intervention trials. PLoS One. 2019;14(1):e0211479. doi: 10.1371/journal.pone.0211479 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Welch JL, Thomas-Hawkins C. Psycho-educational strategies to promote fluid adherence in adult hemodialysis patients: a review of intervention studies. Int J Nurs Stud. 2005;42(5):597–608. doi: 10.1016/j.ijnurstu.2004.09.015 [DOI] [PubMed] [Google Scholar]
  • 12.Crews DC, Hall YN. Social disadvantage: perpetual origin of kidney disease. Adv Chronic Kidney Dis. 2015;22(1):4–5. doi: 10.1053/j.ackd.2014.11.003 [DOI] [PubMed] [Google Scholar]
  • 13.Wileman V Chilcot J Armitage CJ, et al. Evidence of improved fluid management in patients receiving haemodialysis following a self-affirmation theory-based intervention: a randomised controlled trial. Psychol Health. 2016;31(1):100–114. doi: 10.1080/08870446.2015.1073729 [DOI] [PubMed] [Google Scholar]
  • 14.Wileman V Farrington K Chilcot J, et al. Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trial. Ann Behav Med. 2014;48(2):275–281. doi: 10.1007/s12160-014-9597-8 [DOI] [PubMed] [Google Scholar]
  • 15.Tesfaye WH Erku D Mekonnen A, et al. Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel. J Nephrol. 2021;34(4):1091–1125. doi: 10.1007/s40620-020-00895-x [DOI] [PubMed] [Google Scholar]
  • 16.Mechta Nielsen T, Frøjk Juhl M, Feldt-Rasmussen B, Thomsen T. Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research. Clin Kidney J. 2018;11(4):513–527. doi: 10.1093/ckj/sfx140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12(1):181. doi: 10.1186/1471-2288-12-181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Carroll C, Booth A, Leaviss J, Rick J. “Best fit” framework synthesis: refining the method. BMC Med Res Methodol. 2013;13(1):37. doi: 10.1186/1471-2288-13-37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kaveh K, Kimmel PL. Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am J Kidney Dis. 2001;37(2):244–266. doi: 10.1053/ajkd.2001.21286 [DOI] [PubMed] [Google Scholar]
  • 20.Gordon EJ, Leon JB, Sehgal AR. Why are dialysis treatments shortened and skipped? Development of a taxonomy and relationship to patient subgroups. Nephrol Nurs J. 2003;30(2):209–217; discussion 218. [PubMed] [Google Scholar]
  • 21.Carroll C, Booth A, Lloyd-Jones M. Should we exclude inadequately reported studies from qualitative systematic reviews? An evaluation of sensitivity analyses in two case study reviews. Qual Health Res. 2012;22(10):1425–1434. doi: 10.1177/1049732312452937 [DOI] [PubMed] [Google Scholar]
  • 22.Dixon-Woods M, Shaw RL, Agarwal S, Smith JA. The problem of appraising qualitative research. Qual Saf Health Care. 2004;13(3):223–225. doi: 10.1136/qshc.2003.008714 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dixon-Woods M Sutton A Shaw R, et al. Appraising qualitative research for inclusion in systematic reviews: a quantitative and qualitative comparison of three methods. J Health Serv Res Policy. 2007;12(1):42–47. doi: 10.1258/135581907779497486 [DOI] [PubMed] [Google Scholar]
  • 24.Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol. 2009;9(1):59. doi: 10.1186/1471-2288-9-59 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Braun V, Clarke V. What can “thematic analysis” offer health and wellbeing researchers? Int J Qual Stud Health Well-being. 2014;9(1):26152. doi: 10.3402/qhw.v9.26152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sabate E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003. [PubMed] [Google Scholar]
  • 27.O'Brien ME. Compliance behavior and long-term maintenance dialysis. Am J Kidney Dis. 1990;15(3):209–214. doi: 10.1016/s0272-6386(12)80764-5 [DOI] [PubMed] [Google Scholar]
  • 28.Chenitz KB, Fernando M, Shea JA. In-center hemodialysis attendance: patient perceptions of risks, barriers, and recommendations. Hemodial Int. 2014;18(2):364–373. doi: 10.1111/hdi.12139 [DOI] [PubMed] [Google Scholar]
  • 29.Robinson J, Daniels G, Walker C. Experiences of African American older adults living with end-stage renal disease undergoing hemodialysis. J Chi Eta Phi Sorority. 2019:1–29 [Google Scholar]
  • 30.Boehmer KR Pine KH Whitman S, et al. Do patients with high versus low treatment and illness burden have different needs? A mixed-methods study of patients living on dialysis. PLoS One. 2021;16(12):e0260914. doi: 10.1371/journal.pone.0260914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Parker WM, Ferreira K, Vernon L, Cardone KE. The delicate balance of keeping it all together: using social capital to manage multiple medications for patients on dialysis. Res Soc Adm Pharm. 2017;13(4):738–745. doi: 10.1016/j.sapharm.2016.07.008 [DOI] [PubMed] [Google Scholar]
  • 32.Wells SA. Occupational deprivation or occupational adaptation of Mexican Americans on renal dialysis. Occup Ther Int. 2015;22(4):174–182. doi: 10.1002/oti.1394 [DOI] [PubMed] [Google Scholar]
  • 33.Clark-Cutaia MN Sevick MA Thurheimer-Cacciotti J, et al. Perceived barriers to adherence to hemodialysis dietary recommendations. Clin Nurs Res. 2019;28(8):1009–1029. doi: 10.1177/1054773818773364 [DOI] [PubMed] [Google Scholar]
  • 34.Senteio C, Veinot T. Trying to make things right: adherence work in high-poverty, African American neighborhoods. Qual Health Res. 2014;24(12):1745–1756. doi: 10.1177/1049732314549027 [DOI] [PubMed] [Google Scholar]
  • 35.Karolich RL, Ford JP. Meaning, comprehension, and manageability of end-stage renal disease in older adults living with long-term hemodialysis. Soc Work Health Care. 2010;49(1):19–37. doi: 10.1080/00981380902958601 [DOI] [PubMed] [Google Scholar]
  • 36.Smith K Coston M Glock K, et al. Patient perspectives on fluid management in chronic hemodialysis. J Ren Nutr. 2010;20(5):334–341. doi: 10.1053/j.jrn.2009.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Krueger L. Experiences of Hmong patients on hemodialysis and the nurses working with them. Nephrol Nurs J. 2009;36(4):379–387. [PubMed] [Google Scholar]
  • 38.Tijerina MS. Mexican American women's adherence to hemodialysis treatment: a social constructivist perspective. Social Work. 2009;54(3):232–242. doi: 10.1093/sw/54.3.232 [DOI] [PubMed] [Google Scholar]
  • 39.Hirth RA, Greer SL, Albert JM, Young EW, Piette JD. Out-of-pocket spending and medication adherence among dialysis patients in twelve countries. Health Aff. 2008;27(1):89–102. doi: 10.1377/hlthaff.27.1.89 [DOI] [PubMed] [Google Scholar]
  • 40.Chan KE, Thadhani RI, Maddux FW. Adherence barriers to chronic dialysis in the United States. J Am Soc Nephrol. 2014;25(11):2642–2648. doi: 10.1681/asn.2013111160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Umeukeje EM Ngankam D Beach LB, et al. African Americans' hemodialysis treatment adherence data assessment and presentation: a precision-based paradigm shift to support quality improvement activities. Kidney Med. 2022;4(2):100394. doi: 10.1016/j.xkme.2021.10.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Palar K Napoles T Hufstedler LL, et al. Comprehensive and medically appropriate food support is associated with improved HIV and diabetes health. J Urban Health. 2017;94(1):87–99. doi: 10.1007/s11524-016-0129-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Blumrosen C Desta R Cavanaugh KL, et al. Interventions incorporating therapeutic alliance to improve hemodialysis treatment adherence in Black patients with end-stage kidney disease (ESKD) in the United States: a systematic review. Patient Prefer Adherence. 2020;14:1435–1444. doi: 10.2147/ppa.s260684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Obialo C, Zager PG, Myers OB, Hunt WC. Relationships of clinic size, geographic region, and race/ethnicity to the frequency of missed/shortened dialysis treatments. J Nephrol. 2014;27(4):425–430. doi: 10.1007/s40620-013-0035-y [DOI] [PubMed] [Google Scholar]
  • 45.Mokiao R, Hingorani S. Food insecurity and kidney disease: symptoms of structural racism. Clin J Am Soc Nephrol. 2021;16(12):1903–1905. doi: 10.2215/CJN.07860621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dixon-Woods M, Fitzpatrick R, Roberts K. Including qualitative research in systematic reviews: opportunities and problems. J Eval Clin Pract. 2001;7(2):125–133. doi: 10.1046/j.1365-2753.2001.00257.x [DOI] [PubMed] [Google Scholar]
  • 47.Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143–164. doi: 10.1177/1090198104263660 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SUPPLEMENTARY MATERIAL
kidney360-4-041-s001.pdf (85.3KB, pdf)
kidney360-4-041-s002.pptx (222.2KB, pptx)

Articles from Kidney360 are provided here courtesy of American Society of Nephrology

RESOURCES